FDA Adverse Event Injury Summary report: N

ACTIVA

MDR report key: 10052669 · Received May 13, 2020

Report

Report Number
3004209178-2020-08533
Event Type
Injury
Date Received
May 13, 2020
Date of Event
May 12, 2020
Report Date
May 13, 2020
Manufacturer
MEDTRONIC PUERTO RICO OPERATIONS CO.
Product Code
MHY
UDI-DI
00643169864191
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID: 3389S-40, LOT#: V030207, IMPLANTED: (B)(6) 2018, EXPLANTED: (B)(6) 2020, PRODUCT TYPE: LEAD. PRODUCT ID: 3389S-40, LOT#: V030207, IMPLANTED: (B)(6) 2018, EXPLANTED: (B)(6) 2020, PRODUCT TYPE: LEAD. PRODUCT ID: 3708660, SERIAL#: (B)(4), IMPLANTED: (B)(6) 2018, EXPLANTED: (B)(6) 2020, PRODUCT TYPE: EXTENSION. PRODUCT ID :3708660, SERIAL#: (B)(4), IMPLANTED: (B)(6) 2018, EXPLANTED: (B)(6) 2020, PRODUCT TYPE: EXTENSION. OTHER RELEVANT DEVICE(S) ARE: PRODUCT ID: 3389S-40, SERIAL/LOT #: V030207, UBD: 19-JAN-2010, UDI#: (B)(4) ; PRODUCT ID: 3389S-40, SERIAL/LOT #: V030207, UBD: 19-JAN-2010, UDI#: (B)(4) ; PRODUCT ID: 3708660, SERIAL/LOT #: (B)(4), UBD: 21-MAR-2022, UDI#: (B)(4) ; PRODUCT ID: 3708660, SERIAL/LOT #: (B)(4), UBD: 21-MAR-2022, UDI#: (B)(4). IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

INFORMATION WAS RECEIVED FROM A HEALTHCARE PROFESSIONAL (HCP) REGARDING A PATIENT WHO WAS IMPLANTED WITH AN IMPLANTABLE NEUROSTIMULATOR (INS). IT WAS REPORTED THAT THE PATIENT HAD AN INFECTION AT THE POCKET SITE, ALONG THE NECK NEAR THE EXTENSIONS, AND THE SKIN WAS ERODED NEAR THE STIMLOCS. THE PATIENT'S SYSTEM WAS REMOVED. THE ISSUE WAS RESOLVED. NO FURTHER COMPLICATIONS WERE REPORTED/ANTICIPATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
517416 ACTIVA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC PUERTO RICO OPERATIONS CO. 37601 00643169864191

Patients

Seq Age Sex Outcome Treatment
1 69 YR Required Intervention